dc.description.sponsorship | ACKNOWLEDGEMENTS The authors are members of the Group of Spanish Experts for Integrated Viral Hepatitis Diagnosis including: Marina Berenguer (Hospital Universitario y Politécnico La Fe; IIS La Fe y Universidad de Valencia. Valencia), María Buti (Hospital Universitario Valle Hebrón y CIBEREHD del Instituto Carlos III. Barcelona), Xavier Forns (Hospital Clinic. Universidad de Barcelona. IDIBAPS. CIBEREHD. Barcelona), Javier García-Samaniego (Hospital Universitario La Paz. CIBEREHD. IdiPAZ. Madrid), Manuel Hernández Guerra (Hospital Universitario de Canarias, Universidad de La Laguna. Tenerife), Sabela Lens (Hospital Clinic. Universidad de Barcelona. IDIBAPS. CIBEREHD. Barcelona), Elisa Martró (Hospital Universitari Germans Trias i Pujol, Institut d'Investigació Germans Trias i Pujol (IGTP). Badalona, Barcelona), Juan Antonio Pineda (Universidad de Sevilla. Hospital Universitario de Valme. Ciber de Enfermedades Infecciosas CIBERINFEC. Sevilla), Martín Prieto (Hospital Universitario y Politécnico La Fe. Valencia; CIBEREHD, Instituto de Salud Carlos III. Madrid), Francisco Rodríguez-Frías (Hospital Universitario Vall d'Hebron. CIBEREHD. Instituto de investigación Vall d'Hebron (VHIR). Key pointsThe global elimination of viral hepatitis elimination is within reach, and will be facilitated by improving test-ing tools. With a single blood sample, it is now possible to screen and to perform a comprehensive diagnosis for hepatitis B, hepatitis C, hepatitis D and other blood-borne viruses like HIV to link those in need to treatment and care. Automated electronic alerts, for those testing positive to engage with specialist, can also improve linkage to care. Furthermore, to add extra value to the patient and health system, with the same blood sample, it is possible to un-dertake an initial evaluation of liver disease by calculating a non-invasive fibrosis score, such as FIB-4, thereby con-tributing to a complete liver health assessment. Today, a single blood sample can reveal silent and preventable liver diseases that may improve liver health outcomes. Barcelona), Manuel Rodríguez (Hospital Universitario Central de Asturias. Universidad de Oviedo. Instituto de Investigación Sanitaria del Principado de Asturias (ISPA). Oviedo), Miguel Ángel Serra (Universidad de Valencia. Valencia), Juan Turnes (Hospital Universitario de Pontevedra. Pontevedra). This publication has been endorsed by the Spanish Association for the Study of the Liver (AEEH), the Alliance for the Elimination of Viral Hepatitis in Spain (AEHVE), the Viral Hepatitis Study Group (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Society of Digestive Pathology (SEPD). The opinions expressed by the authors do not neces-sarily reflect the official position of SEIMC | es_ES |